National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 62187 [2021-24439]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 214 / Tuesday, November 9, 2021 / Notices
62187
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
FDA center or 21 CFR section and/or FDA form
Total ......................................................................
1 There
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
........................
........................
........................
................................
Total hours
22,716
are no capital costs or operating and maintenance costs associated with this collection of information.
While we have retained the currently
approved burden estimates for the
individual information collection
elements, we have removed those
elements associated with mandatory
electronic reporting inadvertently
included in our 60-day notice, as these
elements are currently approved under
OMB control number 0910–0645.
Dated: November 3, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021–24432 Filed 11–8–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
The meeting will be open to the
public as indicated below, with a short
public comment period at the end. The
open session will be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov).
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Digestive Diseases and Nutrition
Subcommittee.
Date: January 26–27, 2022.
Time: 10:00 a.m. to 1:45 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
VerDate Sep<11>2014
17:00 Nov 08, 2021
Jkt 256001
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Kidney, Urologic and Hematologic
Diseases Subcommittee.
Date: January 26–27, 2022.
Time: 10:00 a.m. to 1:45 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council; Diabetes, Endocrinology and
Metabolic Diseases Subcommittee.
Date: January 26–27, 2022.
Time: 10:00 a.m. to 1:45 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: January 26–27, 2022.
Open: January 26, 2022, 10:00 a.m. to 1:15
p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Closed: January 27, 2022, 1:25 p.m. to 1:45
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Karl F. Malik, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/DEA/
Council/coundesc.htm., where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: November 3, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–24439 Filed 11–8–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Library of
Medicine Board of Scientific
Counselors.
The meeting will be open to the
public as indicated below. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
E:\FR\FM\09NON1.SGM
09NON1
]]>Agencies
[Federal Register Volume 86, Number 214 (Tuesday, November 9, 2021)]
[Notices]
[Page 62187]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24439]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Diabetes
and Digestive and Kidney Diseases Advisory Council.
The meeting will be open to the public as indicated below, with a
short public comment period at the end. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Digestive Diseases and Nutrition
Subcommittee.
Date: January 26-27, 2022.
Time: 10:00 a.m. to 1:45 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected], (301) 594-
4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases
Subcommittee.
Date: January 26-27, 2022.
Time: 10:00 a.m. to 1:45 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council; Diabetes, Endocrinology and Metabolic
Diseases Subcommittee.
Date: January 26-27, 2022.
Time: 10:00 a.m. to 1:45 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: January 26-27, 2022.
Open: January 26, 2022, 10:00 a.m. to 1:15 p.m.
Agenda: To present the Director's Report and other scientific
presentations.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Closed: January 27, 2022, 1:25 p.m. to 1:45 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Karl F. Malik, Ph.D., Director, Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm.,
where an agenda and any additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: November 3, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-24439 Filed 11-8-21; 8:45 am]
BILLING CODE 4140-01-P
